ProCE Banner Activity

Christine Katlama and Babafemi Taiwo: Answering the Questions on Optimizing Antiretroviral Therapy in Heavily Treatment–Experienced People With HIV

Podcast Episodes

Hear from expert faculty as they discuss questions regarding the management of people with HIV who are heavily treatment experienced or experiencing treatment failure.

Released: May 16, 2023

Share

Faculty

Christine Katlama

Christine Katlama, MD

Professor
Sorbonne University APHP Paris
Head, HIV/Hepatitis Clinical and Research Unit
Department of Infectious Diseases
Paris, France

Babafemi Taiwo

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Disclosure

Primary Author

Christine Katlama, MD

Professor
Sorbonne University APHP Paris
Head, HIV/Hepatitis Clinical and Research Unit
Department of Infectious Diseases
Paris, France

Christine Katlama, MD: consultant/advisor/speaker: Gilead, Merck Sharp & Dohme, ViiV Healthcare.

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Babafemi Taiwo, MBBS: consultant/advisor/speaker: Gilead Sciences, GSK, Johnson & Johnson, ViiV Healthcare.